News
1h
Zacks Investment Research on MSNPharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline UpdateNovo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...
Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...
Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...
It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...
In a unique collaboration to raise awareness of haemophilia in Thailand, Danish healthcare company Novo Nordisk and Thai ...
City Hall chiefs point finger at poor work-life balance as stark health data emerges, prompting a new initiative to create a ...
Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster ...
Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results